SCHEMBL7884652

SCHEMBL7884652

CN(C(=N)N)C(=O)c1cc2c(O)cccc2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 3/20 0.48
IDO1 P14902 1/20 0.43
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
HTR6 P50406 1/20 0.38
FLT3 P36888 7/20 0.37
PDGFRB P09619 1/20 0.37
KIT P10721 1/20 0.37
DAO P14920 2/20 0.35
DDO Q99489 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7881205 0.99 HRH4 (0.47) HRH4IDO1GRIN2DGRIN3BGRIN1
SCHEMBL7879486 0.86 FLT3 (0.48) HRH4HTR6FLT3PDGFRBKIT
SCHEMBL7881408 0.86 HRH4 (0.50) HRH4GRIN1HTR6FLT3DAO
SCHEMBL7881372 0.86 HRH4 (0.50) HRH4HTR6FLT3PDGFRBKIT
Hydrochloric Acid SCHEMBL7873299 0.85 HRH4 (0.49) HRH4HTR6FLT3PDGFRBKIT
Hydrochloric Acid SCHEMBL7873711 0.85 FLT3 (0.47) HRH4HTR6FLT3PDGFRBKIT
Hydrochloric Acid SCHEMBL7882136 0.85 HRH4 (0.49) HRH4GRIN1HTR6FLT3DAO
Hydrochloric Acid SCHEMBL7882174 0.84 HRH4 (0.48) HRH4FLT3DAODDO
Hydrochloric Acid SCHEMBL7884740 0.84 HRH4 (0.48) HRH4HTR6FLT3KDM4EALDH1A1
SCHEMBL7882080 0.83 KIF11 (0.38) HRH4HTR6FLT3PDGFRBKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed